PUMA BIOTECHNOLOGY, INC. Equity Method Investment, Ownership Percentage
PUMA BIOTECHNOLOGY, INC. (PBYI) had Equity Method Investment, Ownership Percentage of 100.00% as of 2011-10-31, per its 10-K filed 2014-03-03.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2018-03-09
- 2011-10-31: Equity Method Investment, Ownership Percentage 100.00%.
- 2011-10-04: Equity Method Investment, Ownership Percentage 100.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2011-10-31 | 100.00% 10-K · filed 2014-03-03 |
| 2011-10-04 | 100.00% 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |